Trade Mark Journal No.2026/020 15 May 2026

WO0000001915202 (40)

Office of origin: United States of America

Date of International Registration:20 February 2026
Date of designation in the UK: 20 February 2026
Image for mark 1915202 CLINGUIDE

International priority date claimed: 19 February 2026 (United States of America) (99659690)
Class 40
Manufacturing services for others in the field of drugs for therapeutic use in humans, nucleic acids, and nucleic acid materials; custom manufacturing consultancy; technical support services, namely, providing technical advice related to the manufacture of drugs for therapeutic use in humans, nucleic acids, and nucleic acid materials.

Agilent Technologies, Inc.

Representative: Andrew Roppel Holland & Hart LLP, P.O. Box 8749,, Attn: Trademark Docketing, Denver CO 80201-8749, UNITED STATES OF AMERICA